Results 41 to 50 of about 4,240,909 (230)

Esophageal cyst producing CA19-9 and CA125 [PDF]

Interactive CardioVascular and Thoracic Surgery, 2010
The patient was a 59-year-old woman in whom computed tomography revealed a posterior mediastinal cyst and ovarian cystoma at a medical check-up in March 2007. Blood tests showed high CA19-9 and CA125 levels. She underwent left adnexectomy for ovarian cystoma in July 2008 and histopathological examination led to a diagnosis of dermoid cyst.
Taichiro, Goto, Arafumi, Maeshima, Yoshitaka, Oyamada, Ryoichi, Kato   +3 more
openaire   +2 more sources

Raised CA19-9 in Autoimmune Pancreatitis [PDF]

Journal of Digestive Endoscopy, 2020
AbstractAutoimmune pancreatitis (AIP) is a known autoimmune disorder of the pancreas, with a clinical presentation similar to that of carcinoma of the pancreas. CA19-9 levels can be the distinguishing feature between the two disorders. In rare instances, CA19-9 may be elevated in AIP.
Sridhar Sundaram, Deepak Kumar Gupta
openaire   +2 more sources

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients

Scientific Reports, 2021
Despite the acceptance of carbohydrate antigen 19-9 (CA19-9) as a valuable predictor for the prognosis of pancreatic ductal adenocarcinoma (PDAC), its cutoff value remains controversial.
Fumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Yuji Takayama, Hideki Ishikawa, Nao Kakizawa, Masaaki Saito, Kazushige Futsuhara, Hiroshi Noda, Fumio Konishi, Toshiki Rikiyama   +12 more
doaj   +1 more source

Colorectal cancer: Impact of CEA and CA19-9

, 2023
Colorectal cancer is the third most common cancer world-wide. A diagnosis in early stages, adequate treatment, and a follow-up is vital for a good prognosis in overall and recurrence-free survival. While the tumor marker carcinoembryonic antigen (CEA) is
Lakemeyer, Leilani Ellen
core   +1 more source

The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice [PDF]

, 2019
Glycosylation alterations are indicative of tissue inflammation and neoplasia, but whether these alterations contribute to disease pathogenesis is largely unknown.
Schoepfer, Christina, Da Silva, Brandon, Creighton, Brianna, Spielman, Benjamin, Yu, Kenneth H, Gimotty, Phyllis A, Engle, Dannielle D, Park, Youngkyu, Oni, Tobiloba E, Tiriac, Hervé, Hruban, Ralph H, Tuveson, David A, Afinowicz, Lauren, Whalen, Sean, Rivera, Keith D, Wright, Kevin, Alagesan, Brinda, Lee, Eun Jung, Goggins, Michael G, Hollingsworth, Michael A, Pappin, Darryl J, Grützmann, Robert, Pommier, Arnaud, Aust, Daniela, Lucito, Matthew S, Yao, Melissa A, Pilarsky, Christian, Pollard, Katherine S   +27 more
core   +2 more sources

A case of acute cholecystitis with abnormally high CA19-9

, 2023
Background CA19-9 is strongly expressed in malignant tumors of the digestive system and is widely used as a marker for gastrointestinal cancer. In this report, we describe a case of acute cholecystitis in which CA19-9 was markedly elevated.
Hironobu Kimura, Noboru Yokoyama, Shinichiro Oinuma, Shinya Kasagi, Haruhiro Inoue, Takuya Terunuma, Syunsuke Omotaka, Deguchi Yoshio   +7 more
core   +1 more source

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

Journal of the Anus, Rectum and Colon, 2022
Objectives: We evaluated the prognostic impact of a novel C-reactive protein (CRP) cut-off value (0.6 mg/dl) and carcinoembryonic antigen (CEA)/carbohydrate antigen 19-9 (CA19-9) in stage II/III colorectal cancer.
Mitsunori Ushigome, Hideaki Shimada, Tomoaki Kaneko, Yasuyuki Miura, Yasuo Nagashima, Takayuki Suzuki, Satoru Kagami, Akiharu Kurihara, Kimihiko Funahashi   +8 more
doaj   +1 more source

Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study

Endocrine Journal, 2023
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi   +3 more
doaj   +1 more source

CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma

, 2021
Shao-Cheng Lyu,* Jing Wang,* Mengxiu Huang,* Han-Xuan Wang, Lin Zhou, Qiang He, Ren Lang Department of Hepatobiliary and Pancreaticosplenic Surgery, Beijing ChaoYang Hospital, Capital Medical University, Beijing, 100020, People’s Republic of China ...
Zhou L, Lyu SC, Huang M, Lang R, Wang HX, He Q, Wang J   +6 more
core  

Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study

Frontiers in Oncology, 2022
BackgroundThe prognostic significance of tumor burden score (TBS) on patients who underwent curative-intent resection of intrahepatic cholangiocarcinoma (ICC) has not been evaluated.
Hui Li, Rongqiang Liu, Haizhou Qiu, Yang Huang, Wenbin Liu, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li   +8 more
doaj   +1 more source